Joel Isaacson & Co., LLC Novartis Ag Transaction History
Joel Isaacson & Co., LLC
- $2.18 Billion
- Q4 2024
A detailed history of Joel Isaacson & Co., LLC transactions in Novartis Ag stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 4,677 shares of NVS stock, worth $524,852. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,677
Previous 4,837
3.31%
Holding current value
$524,852
Previous $556,000
18.17%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$771 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$626 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...